Speaker illustration

Professor Carlo Patrono

Catholic University of the Sacred Heart, Rome (Italy)

Prof. Patrono’s main research interest is in the study of platelet activation and inhibition in atherothrombosis and colorectal cancer. His research has characterized the human pharmacology of aspirin as an inhibitor of platelet COX-1 and provided the basis for the development of low-dose aspirin as an antithrombotic agent. Moreover, Prof. Patrono contributed to characterizing the human pharmacology of COX-2 inhibitors and evaluating their cardiovascular effects in different clinical settings. He is an elected member of the Association of American Physicians, Royal College of Physicians, Academia Europaea and Accademia dei Lincei. He has received the 2013 Grand Prix Scientifique awarded by the Institut de France. He is a Section Editor of the Journal of the American College of Cardiology and Associate Editor of the International Journal of Cardiology. Prof. Patrono has published over 240 research articles with approx 65,000 citations and an h-index of 106.

Diabetes: targeting the increase in cardiovascular risk

Event: EuroThrombosis and EuroVessels 2022

Topic: Thrombosis, Bleeding

Session type: Teaching Course


Platelets, haemostasis and coagulation

Event: ESC Congress 2018

Topic: Vascular Biology and Physiology

Session type: Rapid Fire Abstracts


Aspirin at 120: cardioprotection and beyond

Event: ESC Congress 2017

Topic: Drug therapy

Session type: Satellite Symposium


ESC Guidelines - Acute Coronary Syndromes Non-ST-Elevation

Event: ESC Congress 2015

Topic: Infarction acute phase non STEMI

Session type: New ESC Guidelines


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb